Annovis Bio, Inc. (ANVS)

Annovis Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12.64	5.75	28.38	45.69	8.07	0
Cash & Short-Term Investments	12.64	5.75	28.38	45.69	8.07	0
Cash Growth	98.85%	-79.72%	-37.89%	465.80%	434488.70%	-94.74%
Other Receivables	-	-	-	-	-	0.74
Receivables	-	-	-	-	-	0.74
Prepaid Expenses	0.25	0.04	0.1	0.07	0.04	0
Other Current Assets	1.47	4.41	7.54	0.24	0.01	0.01
Total Current Assets	14.36	10.21	36.02	46	8.12	0.75
Long-Term Deferred Charges	-	-	-	-	-	0.37
Total Assets	14.36	10.21	36.02	46	8.12	1.12
Accounts Payable	4.1	1.29	3.96	0.69	0.34	1.23
Accrued Expenses	1.29	2.99	3.74	0.82	0.24	0.78
Total Current Liabilities	5.39	4.28	7.7	1.51	0.58	2.01
Long-Term Debt	-	-	-	-	-	0.5
Other Long-Term Liabilities	1.91	13.68	-	-	-	0.11
Total Liabilities	7.3	17.96	7.7	1.51	0.58	2.62
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	136.05	102.51	82.38	73.22	21.78	0.2
Retained Earnings	-128.98	-110.26	-54.05	-28.73	-14.24	-8.78
Total Common Equity	7.06	-7.75	28.32	44.49	7.54	-8.58
Shareholders' Equity	7.06	-7.75	28.32	44.49	7.54	-1.5
Total Liabilities & Equity	14.36	10.21	36.02	46	8.12	1.12
Total Debt	-	-	-	-	-	0.5
Net Cash (Debt)	12.64	5.75	28.38	45.69	8.07	-0.5
Net Cash Growth	98.85%	-79.72%	-37.89%	465.80%	-	-
Net Cash Per Share	1.15	0.64	3.48	5.99	1.28	-1.76
Filing Date Shares Outstanding	13.8	11.01	8.22	8.16	6.95	6.85
Total Common Shares Outstanding	13.28	10.52	8.16	8.1	6.89	0.28
Working Capital	8.97	5.93	28.32	44.49	7.54	-1.26
Book Value Per Share	0.53	-0.74	3.47	5.49	1.09	-30.35
Tangible Book Value	7.06	-7.75	28.32	44.49	7.54	-8.58
Tangible Book Value Per Share	0.53	-0.74	3.47	5.49	1.09	-30.35

Source: S&P Capital IQ. Standard template. Financial Sources.